Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) was characterized as an autoimmune condition with the production of antiphospholipid antibodies (aPL) associated with thrombosis and morbidity in pregnancy. The prevalence of aPL in the population ranges from 1% to 5% in patients with APS. The hypotheses regarding pat...
Main Authors: | Thaís da Silva Santos, Izabel Galhardo Demarchi, Tatiane França Perles Mello, Jorge Juarez Vieira Teixeira, Maria Valdrinez Campana Lonardoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Hospital de Clínicas de Itajubá
2019-11-01
|
Series: | Revista Ciências em Saúde |
Subjects: | |
Online Access: | http://186.225.220.186:7474/ojs/index.php/rcsfmit_zero/article/view/892 |
Similar Items
-
ANTIPHOSPHOLIPID ANTIBODIES, THEIR PATHOGENETIC AND DIAGNOSTIC ISSUES OBSTETRIC PRACTICE
by: V. O. Bitsadze, et al.
Published: (2016-06-01) -
Management of Antiphospholipid Syndrome
by: Amine Ghembaza, et al.
Published: (2020-11-01) -
RECURRENT FETAL LOSS IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME (CASE REPORT)
by: Z S Alekberova, et al.
Published: (2000-02-01) -
Antiphospholipid syndrome and cancer
by: Razvan Adrian Ionescu
Published: (2021-03-01) -
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies
by: Cecilia Nalli, et al.
Published: (2021-06-01)